Push to curb Paracetamol sales
Two medical researchers are calling for tighter controls on paracetamol sales after their hospital audit found it is the drug of choice for self-harm, especially among teenage girls.
Two medical researchers are calling for tighter controls on paracetamol sales after their hospital audit found it is the drug of choice for self-harm, especially among teenage girls.
It was absolutely astounding to see kids were able to play more sports and had less wheezing and coughing.
Tim Groser has a sales job in front of him after the Trans-Pacific Partnership kept the doors open wide to foreign investment in Auckland's red hot housing market.
Most people will be more than aware that, like all public relations campaigns, this one will not reveal the full picture.
FRAN O'SULLIVAN: Geneva has the WTO. Brussels hosts the European Union. Will the Trans-Pacific Partnership put Auckland on the map?
The TPP could be improved after a few years, Trade Minister Tim Groser has said, acknowledging NZ lost against powerful forces that limited dairy sector rewards.
New Zealand and 11 other countries strike Pacific trade pact - a deal that will affect 40 per cent of world's economy.
What deals have other countries by signing up to the TPP deal?
OPINION: Trade Minister conceded a few nasty points but his brinksmanship in TPP negotiations allows him to stare down critics, writes Fran O'Sullivan.
New Zealand scientist Jilly Evans will have you believe it was luck that made her one of the world's leading researchers in the development of therapies for cancer and arthritis.
"Making normal sexuality into a medical problem is an easy PR task with enduring serious consequences for the health of NZ women."
Adherium wants to raise as much as A$35 million from Australian and Kiwi investors to help fund the commercial roll-out of its product and continue research and development.
Should we be dismayed or relieved at the disarray the Trans-Pacific Partnership negotiations are in? Sorry, but on the information to hand it is impossible to say.
A nurse who stole 5000 vials from a restricted medicine room was able to keep taking the drug because the hospital did not confiscate her ID swipe card.
The first drug that slows down Alzheimer's disease could be available within three years after trials showed it prevented mental decline by a third.
An active ingredient in a cream used to treat head lice and scabies has been linked to causing cancer and will be withdrawn from sale in New Zealand.
It's said to cure women's low libido by making sex more pleasurable. But with fears over side-effects, many doctors are sceptical.
A former pharmacist who was found guilty of selling and supplying drugs to clients had his registration cancelled by the Health Practitioner's Disciplinary Tribunal.
Panadeine, Nurofen Plus and other medicines containing codeine should be banned from over-the-counter sales, say top pain medicine experts.
A promising lung cancer drug has been rescued by a new American sponsor after a potentially disastrous finding of "unacceptable toxicity" in some patients.
An ointment used to treat common childhood skin infections is driving the rise of antibiotic-resistant superbugs.
A woman's fertility procedure had to be abandoned because she was taking the wrong medication, owing to a mistake by a pharmacist.
A woman spent five days in hospital recovering from liver problems caused by being given the wrong medicine by a pharmacist.
A pharmacist who stole prescription drugs from his former employer, including erectile dysfunction medication and the morning-after pill, has been deregistered.
Douglas Pharmaceuticals, New Zealand's largest developer and manufacturer of generic pharmaceuticals, is targeting annual revenues of $244 million by 2020.
To maintain overall good health, the Chinese don't usually take vitamin pills or health supplements - they drink soup.
A teenager with a life-threatening illness has had a "miracle" response to a drug Pharmac said it wouldn't fund.
It took months of planning, a nine-hour surgery and a team of 35 clinicians. But by the end, they had completed a ground-breaking double arm transplant on a quadruple amputee.
It costs drugmakers US$2.56 billion to bring a new medicine to market - more than double the price of 11 years ago.